/OGI
OGI Stock - Organigram Global Inc.
Healthcare|Drug Manufacturers - Specialty & GenericNASDAQ
$2.01-0.99%
$0.02 (-0.99%) • Dec 19
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.96
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.30
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.21
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OGI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.99 – $2.03
TARGET (TP)$2.31
STOP LOSS$1.85
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.26
52W High$2.24
52W Low$0.85
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $186.09M | $159.84M | $149.21M | $145.81M | $79.16M |
| Gross Profit | $6.83M | $47.52M | $35.07M | $31.57M | $-28,399,000 |
| Gross Margin | 3.7% | 29.7% | 23.5% | 21.7% | -35.9% |
| Operating Income | $-63,405,144 | $-35,671,000 | $-242,739,000 | $-43,151,000 | $-91,820,000 |
| Net Income | $-17,776,962 | $-45,440,000 | $-229,478,000 | $-14,283,000 | $-130,704,000 |
| Net Margin | -9.6% | -28.4% | -153.8% | -9.8% | -165.1% |
| EPS | $-0.14 | $-0.48 | $-2.82 | $-0.18 | $-2.04 |
Company Overview
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
3 Bullish0 Neutral/Bearish
Price Targets
No price targets available
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 17th 2024 | Canaccord Genuity | Resumed | Speculative Buy | - |
| April 15th 2024 | Alliance Global Partners | Upgrade | Buy | - |
| January 13th 2023 | Stifel | Upgrade | Buy | - |
Earnings History & Surprises
OGIBeat Rate
11%
Last 18 quarters
Avg Surprise
-163.2%
EPS vs Estimate
Beats / Misses
2/13
3 met exactly
Latest EPS
$-0.20
Q4 2025
EPS Surprise History
Q4 23
+71.4%
$-0.04vs$-0.14
Q1 24
-40.0%
$-0.14vs$-0.10
Q2 24
-100.0%
$-0.12vs$-0.06
Q3 24
+140.0%
$0.02vs$-0.05
Q4 24
-33.3%
$-0.04vs$-0.03
Q1 25
-66.7%
$-0.05vs$-0.03
Q3 25
-200.0%
$-0.03vs$-0.01
Q4 25
-1900.0%
$-0.20vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 10, 2026 | $-0.01 | — | — | — |
Q4 2025 | Dec 16, 2025 | $-0.01 | $-0.20 | -1900.0% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | $-0.01 | $-0.03 | -200.0% | ✗ MISS |
Q1 2025 | Feb 11, 2025 | $-0.03 | $-0.05 | -66.7% | ✗ MISS |
Q4 2024 | Dec 18, 2024 | $-0.03 | $-0.04 | -33.3% | ✗ MISS |
Q3 2024 | Aug 13, 2024 | $-0.05 | $0.02 | +140.0% | ✓ BEAT |
Q2 2024 | May 14, 2024 | $-0.06 | $-0.12 | -100.0% | ✗ MISS |
Q1 2024 | Feb 13, 2024 | $-0.10 | $-0.14 | -40.0% | ✗ MISS |
Q4 2023 | Dec 19, 2023 | $-0.14 | $-0.04 | +71.4% | ✓ BEAT |
Q3 2023 | Jul 13, 2023 | $-0.05 | $-0.15 | -200.0% | ✗ MISS |
Q2 2023 | Apr 11, 2023 | $-0.07 | $-0.08 | -20.0% | ✗ MISS |
Q1 2023 | Jan 12, 2023 | $-0.01 | $-0.04 | -184.9% | ✗ MISS |
Q4 2022 | Nov 28, 2022 | $-0.08 | $-0.08 | 0.0% | = MET |
Q3 2022 | Jul 14, 2022 | $-0.08 | $-0.12 | -50.0% | ✗ MISS |
Q2 2022 | Apr 12, 2022 | $-0.08 | $-0.08 | 0.0% | = MET |
Q1 2022 | Jan 11, 2022 | $-0.07 | $-0.12 | -80.0% | ✗ MISS |
Q4 2021 | Nov 23, 2021 | $-0.16 | $-0.28 | -75.0% | ✗ MISS |
Q3 2021 | Jul 13, 2021 | $-0.12 | $-0.12 | 0.0% | = MET |
Q2 2021 | Apr 13, 2021 | $-0.12 | $-0.36 | -200.0% | ✗ MISS |
Latest News
'Trump's Marijuana Executive Order Details Leaked Ahead Of Announcement, Including CBD And Hemp Provisions'- Marijuana Moment
📈 PositiveBenzinga•Dec 18, 2025, 05:50 PM•Also: , ,
Shares of cannabis-linked stocks are trading higher following reports suggesting President Trump will sign an executive order that will reclassify marijuana to a Schedule III drug.
📈 PositiveBenzinga•Dec 17, 2025, 02:38 PM•Also: , ,
Shares of cannabis-linked stocks are trading higher after President Donald Trump confirmed his administration is strongly considering reclassifying marijuana.
📈 PositiveBenzinga•Dec 16, 2025, 07:17 PM•Also: , ,
OrganiGram Holdings Q4 EPS $(0.20) Misses $(0.01) Estimate, Sales $58.151M Beat $53.140M Estimate
➖ NeutralBenzinga•Dec 16, 2025, 01:36 PM
OrganiGram Holdings Q4 EPS $(0.28) Misses $(0.01) Estimate, Sales $80.061M Beat $65.067M Estimate
➖ NeutralBenzinga•Dec 16, 2025, 01:33 PM
Shares of cannabis-linked stocks are trading higher following a report suggesting that President Trump is expected to reclassify marijuana as a Schedule III drug.
📈 PositiveBenzinga•Dec 12, 2025, 01:23 PM•Also: , ,
Organigram Global Appoints James Yamanaka, Former Global Head Of Strategy For British American Tobacco, As The Company's New CEO, Effective On Or About January 15, 2026
📈 PositiveBenzinga•Nov 25, 2025, 11:01 AM•Also:
Organigram Global Extends CEO Beena Goldenberg's Tenure To November 30, 2025 To Support Ongoing CEO Search And Ensure Operational Continuity
➖ NeutralBenzinga•Oct 21, 2025, 10:13 AM
Organigram Launches happly, New Hemp-Derived Delta-9 Brand for Mindful THC Recreation in US Market
📈 PositiveBenzinga•Oct 9, 2025, 10:08 AM•Also:
Governor Newsom Signs Legislation Cutting Taxes On Cannabis, Promoting The Long-Term Success Of The Legal Industry
📈 PositiveBenzinga•Sep 22, 2025, 05:25 PM•Also: , ,
'Marijuana Industry Group Pushes Congress For Tax Relief—And To Apply The Fix Retroactively For Past Payments'- Marijuana Moment
📈 PositiveBenzinga•Sep 18, 2025, 06:16 PM•Also: , ,
'Trump's Drug Czar Pick Says Marijuana Is A 'Bipartisan Issue,' But Admin Still Exploring 'All Options' On Scheduling' - Marijuana Moment
➖ NeutralBenzinga•Sep 17, 2025, 05:26 PM•Also: , ,
Marijuana Herald Founder And Editor-in-Chief Anthony Martinelli Posts On X "The DOJ cleaned house but kept rescheduling alive. Congress is about to overwhelmingly approve medical cannabis for veterans.
📈 PositiveBenzinga•Sep 11, 2025, 06:04 PM•Also: , ,
Shares of cannabis stocks are trading higher amid a new Republican National Committee leader who supports legalization.
📈 PositiveBenzinga•Aug 25, 2025, 05:00 PM•Also: , ,
Frequently Asked Questions about OGI
What is OGI's current stock price?
Organigram Global Inc. (OGI) is currently trading at $2.01 per share. The stock has moved -0.99% today.
What is the analyst price target for OGI?
No analyst price targets are currently available for this stock.
What sector is Organigram Global Inc. in?
Organigram Global Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.
What is OGI's market cap?
Organigram Global Inc. has a market capitalization of $0.27 billion, making it a small-cap company.
Does OGI pay dividends?
No, Organigram Global Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACB
Aurora Cannabis Inc.
$4.96
Mkt Cap: $0.3B
DERM
Journey Medical Corporation
$7.87
Mkt Cap: $0.2B
ELMD
Electromed, Inc.
$28.62
Mkt Cap: $0.2B
HSDT
Solana Company
$2.98
Mkt Cap: $0.1B
INFU
InfuSystem Holdings, Inc.
$9.20
Mkt Cap: $0.2B
IVA
Inventiva S.A.
$4.21
Mkt Cap: $0.2B
LFCR
Lifecore Biomedical, Inc.
$8.04
Mkt Cap: $0.3B
OBIO
Orchestra BioMed Holdings, Inc.
$4.35
Mkt Cap: $0.2B
RNAC
Cartesian Therapeutics, Inc.
$7.22
Mkt Cap: $0.2B
SXTC
China SXT Pharmaceuticals, Inc.
$1.61
Mkt Cap: $0.2B
Explore stocks similar to OGI for comparison